Literature DB >> 20665727

Neonatal ventral hippocampus lesion induces increase in nitric oxide [NO] levels which is attenuated by subchronic haloperidol treatment.

José Vicente Negrete-Díaz1, Eduardo Baltazar-Gaytán, María Elena Bringas, Rubén Antonio Vazquez-Roque, Stephanie Newton, Patricia Aguilar-Alonso, Bertha Alicia León-Chávez, Gonzalo Flores.   

Abstract

Haloperidol is a potent dopamine receptor antagonist and used to treat psychotic disorders, such as schizophrenia. Recent clinical and preclinical studies demonstrated the overactivity of the nitric oxide (NO) system in schizophrenia. Neonatal ventral hippocampal (nVH) lesions in rats have been widely used as a neurodevelopmental model that mimics schizophrenia-like behaviors. Here, we investigate first whether the nVH lesion causes changes in NO levels in different limbic brain regions in young adults, postnatal day (PD) 81, and second, whether haloperidol treatment from PD60 to PD81 reverses these changes, by determining the accumulation of nitrites. The results show that NO levels at the level of the prefrontal cortex, occipital cortex, and cerebellum are higher in the nVH lesion animals, and that the haloperidol, in part, attenuates these altered NO levels. The NO levels observed in the nVH lesion animals with and without haloperidol treatment may be relevant to behaviors observed in schizophrenia.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20665727     DOI: 10.1002/syn.20835

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  7 in total

1.  Chronic administration of the neurotrophic agent cerebrolysin ameliorates the behavioral and morphological changes induced by neonatal ventral hippocampus lesion in a rat model of schizophrenia.

Authors:  Rubén Antonio Vázquez-Roque; Brenda Ramos; Carolina Tecuatl; Ismael Juárez; Anthony Adame; Fidel de la Cruz; Sergio Zamudio; Raúl Mena; Edward Rockenstein; Eliezer Masliah; Gonzalo Flores
Journal:  J Neurosci Res       Date:  2011-09-19       Impact factor: 4.164

2.  Neonatal exposure to phenobarbital potentiates schizophrenia-like behavioral outcomes in the rat.

Authors:  S K Bhardwaj; P A Forcelli; G Palchik; K Gale; L K Srivastava; A Kondratyev
Journal:  Neuropharmacology       Date:  2012-02-15       Impact factor: 5.250

3.  Risperidone Ameliorates Prefrontal Cortex Neural Atrophy and Oxidative/Nitrosative Stress in Brain and Peripheral Blood of Rats with Neonatal Ventral Hippocampus Lesion.

Authors:  Hiram Tendilla-Beltrán; Silvia Meneses-Prado; Rubén Antonio Vázquez-Roque; Miguel Tapia-Rodríguez; Andrea Judith Vázquez-Hernández; Heriberto Coatl-Cuaya; David Martín-Hernández; Karina S MacDowell; Linda Garcés-Ramírez; Juan C Leza; Gonzalo Flores
Journal:  J Neurosci       Date:  2019-09-13       Impact factor: 6.167

Review 4.  The use of antioxidant compounds in the treatment of first psychotic episode: Highlights from preclinical studies.

Authors:  Stefania Schiavone; Luigia Trabace
Journal:  CNS Neurosci Ther       Date:  2018-03-14       Impact factor: 5.243

5.  Critical role of nitric oxide in the modulation of prepulse inhibition in Swiss mice.

Authors:  Ana C Issy; João Francisco C Pedrazzi; Bruno H Yoneyama; Elaine A Del-Bel
Journal:  Psychopharmacology (Berl)       Date:  2013-10-08       Impact factor: 4.530

6.  Atypical antipsychotics, more than just an antipsychotic.

Authors:  Hiram Tendilla-Beltran; Gonzalo Flores
Journal:  Neural Regen Res       Date:  2020-08       Impact factor: 5.135

Review 7.  Effects of antipsychotics on dentate gyrus stem cell proliferation and survival in animal models: a critical update.

Authors:  Gerburg Keilhoff; Paolo Fusar-Poli; Axel Becker
Journal:  Neural Plast       Date:  2012-10-24       Impact factor: 3.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.